The long search for a drug to slow the decline of Alzheimer’s may have reached a turning point. Pharmaceutical companies Biogen and Eisai have…
We know that as much as 50 percent of dementia patients experience regular pain. But does providing a common painkiller help or hurt patients?…
After years of failure, including some pharmaceutical companies calling off Alzheimer’s research altogether, Biogen offers a glimmer of hope: New data from a Phase…
Could an aspirin a day keep dementia away? A new study has added to the list of evidence that anti-inflammatories like aspirin might be…
Long-term use of certain drugs, some of them used to treat depression, has been linked to an increase in dementia risk in a study…
Jasja De Smedt Kotterman, whose mother died of Alzheimer’s in 2017, said she was always fearful that her mother was in pain toward the end…
Any Alzheimer’s drug under development has a complicated journey from formulation to clinical trials to potentially getting in the hands of patients. We spoke…
Sign up for a weekly digest of the latest research on Alzheimer’s and brain health.
Follow us